MiMedx Group Company Profile (NASDAQ:MDXG)

Analyst Ratings

Consensus Ratings for MiMedx Group (NASDAQ:MDXG) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.17 (47.90% upside)

Analysts' Ratings History for MiMedx Group (NASDAQ:MDXG)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016First AnalysisDowngradeOverweight -> Equal Weight$14.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Lake Street CapitalLower Price TargetBuy$15.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016Needham & Company LLCLower Price TargetStrong-Buy$13.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2016Canaccord GenuityReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Northland SecuritiesUpgradeMarket Perform -> Outperform$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for MiMedx Group (NASDAQ:MDXG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
7/26/2016Q216$0.07$0.05$56.49 million$57.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2016Q116$0.05$0.04$54.05 million$53.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415$0.06$0.12$51.84 million$51.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315$0.06$0.06$48.61 million$49.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$0.04$0.05$45.03 million$45.68 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2015Q1$0.03$0.04ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414$0.03$0.03$38.15 million$39.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314$0.02$0.03$33.50 million$33.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2014Q114($0.02)($0.01)$19.09 million$19.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q4($0.01)($0.04)$18.31 million$18.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013($0.01)($0.01)$12.94 million$13.52 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q1 2013($0.02)($0.02)$11.34 million$11.56 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MiMedx Group (NASDAQ:MDXG)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.03$0.05$0.04
Q2 20163$0.02$0.06$0.05
Q3 20163$0.05$0.08$0.07
Q4 20163$0.08$0.13$0.10
Q1 20172$0.06$0.10$0.08
Q2 20171$0.12$0.12$0.12
Q3 20171$0.13$0.13$0.13
Q4 20171$0.12$0.12$0.12
(Data provided by Zacks Investment Research)

Dividends

Dividend History for MiMedx Group (NASDAQ:MDXG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MiMedx Group (NASDAQ:MDXG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/16/2016William Charles TaylorCOOSell24,333$7.52$182,984.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Parker H PetitCEOBuy20,000$6.99$139,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Parker H PetitCEOBuy30,000$6.82$204,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Parker H PetitCEOBuy40,000$6.75$270,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Parker H PetitCEOBuy50,000$6.74$337,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2015Charles Robert EvansDirectorBuy10,000$7.84$78,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Parker H PetitCEOBuy131,925$7.58$999,991.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015Alexandra O. HadenGeneral CounselBuy4,150$7.92$32,868.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Larry W PapasanDirectorSell5,958$10.09$60,116.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2015William Charles TaylorCOOSell150,000$10.01$1,501,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014William Charles TaylorCOOSell150,000$10.01$1,501,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014William Charles TaylorCOOSell150,000$7.50$1,125,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/17/2014Parker PetitCEOSell150,000$8.28$1,242,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013William Charles TaylorCOOSell9,800$6.15$60,270.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013William Charles TaylorCOOSell183,765$6.21$1,141,180.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Steve GorlinDirectorSell30,000$6.46$193,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for MiMedx Group (NASDAQ:MDXG)
DateHeadline
07/27/16 05:26 PMTraders Recap - JetBlue Airways Corporation, (NASDAQ:JBLU), MiMedx Group, (NASDAQ:MDXG) - Hot Stocks Point
07/27/16 05:26 PMMiMedx Group, Inc. (NASDAQ:MDXG) at $7.53: How much higher it can go - Review Fortune
07/27/16 10:40 AMEdited Transcript of MDXG earnings conference call or presentation 26-Jul-16 2:30pm GMT -
07/26/16 05:26 PMMiMedx meets 2Q profit forecasts
07/25/16 05:16 PMMiMedx Group Inc (MDXG) Shares are Down -2.63% - Trade Calls
07/25/16 06:30 AMMiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo - [PR Newswire] - MARIETTA, Ga., July 25, 2016 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today its expansion of its regenerative medicine portfolio with plans for the nationwide launch of the Company's next generation new lyophilized version of OrthoFlo. The lyophilized version of OrthoFlo is an extension of the Company's amniotic fluid product family, and it provides superior product safety characteristics and enhanced logistical capabilities. Lyophilization, often referred to as freeze drying, is a process in which water is removed from a product after it is frozen and placed under a vacuum, allowing the ice to change directly from solid to vapor without passing through a liquid phase.
07/23/16 09:03 AMTop Earnings to Watch for: MiMedx (NASDAQ:MDXG) - The Voice Registrar
07/22/16 05:01 PMAnalysts Trends to Watch: Mast Therapeutics, Inc. (NYSEMKT:MSTX) , MiMedx Group, Inc (NASDAQ:MDXG) - Street Updates
07/22/16 05:01 PMFirms and Funds Increasing Their Stake in MiMedx Group, Inc. (NASDAQ:MDXG) - Engelwood Daily
07/22/16 05:01 PMWhat's The Growth Forecast For MiMedx Group, Inc (NASDAQ:MDXG)? - RealistInvestor.com
07/20/16 07:17 AMMiMedx Group, Inc. breached its 50 day moving average in a Bearish Manner : MDXG-US : July 20, 2016 -
07/15/16 09:32 AMMiMedx Group Inc Realized Volatility Hits Substantially Low Level - CML News
07/15/16 09:32 AMMiMedx Group Inc (MDXG) is Trading Higher on Unusual Volume for July 12 - Equities.com
07/15/16 09:32 AMMiMedx Group, Inc (NASDAQ:MDXG)'s Growth Projection - RealistInvestor.com
07/15/16 09:32 AMMiMedx Group Inc (MDXG): Price Target and June Short Interest Disclosure - Trade Calls
07/13/16 08:05 AMStock to Watch as it Gaps Up: MiMedx Group, Inc. (NASDAQ:MDXG) - Telanagana Press
07/13/16 08:05 AMShort Term Rating on MiMedx Group Inc (MDXG) - TheFounders Daily
07/12/16 03:39 PMMIMEDX GROUP, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi -
07/12/16 09:31 AMStock Performance Rundown on: MiMedx Group, Inc. (NASDAQ:MDXG) - Press Telegraph
07/12/16 09:31 AMStock Down on the Year MiMedx Group, Inc. (NASDAQ:MDXG) - Press Telegraph
07/12/16 09:31 AMMiMedx Group (MDXG) Q2 Revenue Results Outpace Expectations - StreetInsider.com
07/11/16 05:09 PMMiMedx Second Quarter Of 2016 Revenue Exceeds Upper End Of Guidance Range
07/08/16 05:14 PMWill MiMedx Group, Inc (NASDAQ:MDXG) Surprise This Quarter? - Investor Newswire
07/08/16 05:14 PMShort Information Review for: MiMedx Group, Inc. (NASDAQ:MDXG) - Engelwood Daily
07/08/16 05:14 PMMiMedx Group, Inc (MDXG) Current Analyst Ratings - Fiscal Standard
07/08/16 05:14 PMMiMedx Group (MDXG) Names New VP of Key Strategic Initiatives - StreetInsider.com
07/08/16 05:13 PMMiMedx Group, Inc (NASDAQ:MDXG) Receives Update on Growth Forecast - RealistInvestor.com
07/07/16 07:30 AMMiMedx Adds New Executive - [PR Newswire] - MARIETTA, Ga., July 7, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market ...
07/05/16 04:09 AMShare Performance Recap for: MiMedx Group, Inc. (NASDAQ:MDXG) - Press Telegraph
07/05/16 04:09 AMMiMedx Group, Inc (MDXG) Broker Price Targets For The Coming Week - Fiscal Standard
06/29/16 05:00 PMIt Seems MiMedx Group Inc Will Go Up. Have Another Big Increase - Press Telegraph
06/29/16 07:57 AMEquity Research and Technical Review on MiMedx Group, Inc (NASDAQ:MDXG) - Press Telegraph
06/29/16 07:57 AMMiMedx Group Inc (MDXG) Jumps 8.16% on June 28 - Equities.com
06/28/16 09:57 AMMimedx Group Incorporated (NASDAQ:MDXG) Shorted Shares Decreased By 0.77% - Press Telegraph
06/27/16 08:17 AMMiMedx Group, Inc. breached its 50 day moving average in a Bearish Manner : MDXG-US : June 27, 2016 -
06/25/16 08:53 AMMiMedx Group, Inc (NASDAQ:MDXG): Growth Forecast - RealistInvestor.com
06/22/16 05:01 PMMiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims
06/22/16 09:52 AMMiMedx Group (MDXG), Medline Industries, Liventa Bioscience Enter Settlement Agreement - StreetInsider.com
06/21/16 04:48 PMMiMedx Group (MDXG), Medline Industries, Liventa Bioscience Enter Settlement Agreement
06/21/16 08:03 AMResearch Report Initiated on Select Healthcare Equities -
06/20/16 05:52 AMMiMedx Group, Inc (MDXG) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 09:25 AMAnalyst’s Ratings on: MiMedx Group (NASDAQ:MDXG)
06/17/16 11:09 AMMiMedx Group, Inc. – Value Analysis (NASDAQ:MDXG) : June 17, 2016 -
06/15/16 07:27 AMMiMedx Group, Inc. breached its 50 day moving average in a Bearish Manner : MDXG-US : June 15, 2016 -
06/08/16 05:28 PMMIMEDX GROUP INC. (NASDAQ:MDXG) Financial Condition Compared to S&P 500 - CML News
06/06/16 08:50 AMTwo Buzzers to Observe: Cigna Corporation (NYSE:CI) , MiMedx Group, Inc (NASDAQ:MDXG) - Street Updates
06/04/16 05:06 PMBuy Rating Stocks: MiMedx Group, Inc. (NASDAQ:MDXG), Advanced Semiconductor Engineering Inc. (NYSE:ASX) - Beacon Chronicle
06/02/16 05:28 PMRecent Update on Price Movements: MiMedx Group, Inc (NASDAQ:MDXG) , Rexahn Pharmaceuticals, Inc. (NYSEMKT ... - Street Updates - Recent Update on Price Movements: MiMedx Group, Inc (NASDAQ:MDXG) , Rexahn Pharmaceuticals, Inc. (NYSEMKT ...Street UpdatesMiMedx Group, Inc. (MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports ...
06/02/16 08:01 AMPrice Target by Brokers: Verint Systems Inc. (NASDAQ:VRNT), MiMedx Group, Inc. (NASDAQ:MDXG) - Beacon Chronicle - Price Target by Brokers: Verint Systems Inc. (NASDAQ:VRNT), MiMedx Group, Inc. (NASDAQ:MDXG)Beacon ChronicleLast Trade: The Company closed its last session at $33.44 with the gain of 1.36%. The market capitalization of the company is $2.07 Billion, with the average Volume of 707.30K. The stock currently has its 52-Week High range of $66.17 and 52-week low ...and more »
06/02/16 08:01 AMMiMedx Group, Inc (NASDAQ:MDXG) Stock Update & Estimates - Stock Tick Tock - MiMedx Group, Inc (NASDAQ:MDXG) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting MiMedx Group, Inc (NASDAQ:MDXG) to post earnings of $0.04 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued ...

Social

About MiMedx Group

MiMedx Group logoMiMedx Group, Inc. (MiMedx) is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues and human skin and bone. The Company operates in the Regenerative Biomaterials business segment, which includes the development, processing and marketing of regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues in the wound care, surgical, sports medicine, ophthalmic and dental market categories. Its biomaterial platform technologies are AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix. AmnioFix and EpiFix are its tissue technologies processed from human amniotic membrane derived from donated placentas. The Company processes the human amniotic membrane utilizing its PURION Process, to produce an implant. MiMedx is the supplier of amniotic tissue, having supplied over 500,000 allografts.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MDXG
  • CUSIP:
Key Metrics:
  • Previous Close: $7.55
  • 50 Day Moving Average: $7.82
  • 200 Day Moving Average: $8.00
  • P/E Ratio: 35.78
  • P/E Growth: 1.86
  • Market Cap: $830.67M
  • Beta: 0.74
  • Current Year EPS Consensus Estimate: $0.21 EPS
  • Next Year EPS Consensus Estimate: $0.35 EPS
Additional Links:
MiMedx Group (NASDAQ:MDXG) Chart for Thursday, July, 28, 2016